Company Filing History:
2 out of 10 
1 out of 1 Years Active: 2023-2025
Title: The Innovative Work of Oleh Zagrijtschuk in Pharmaceutical Advancements
Introduction
Oleh Zagrijtschuk, a notable inventor based in Vienna, Austria, has made significant contributions in the field of pharmaceuticals. With one patented invention to his name, he is recognized for his advancements in treatment regimens that focus on critical health issues such as infectious diseases and cancer.
Latest Patents
Zagrijtschuk’s patent, titled "Dosage regimen for pegylated interferon," introduces a pegylated type I interferon that is utilized in the treatment of infectious diseases, cancer, or myeloproliferative diseases. This innovative formulation proposes administering a dose between 50 to 540 µg of pegylated type I interferon at regular intervals ranging from 3 to 8 weeks, tailored for subjects requiring this therapy.
Career Highlights
Currently, Oleh Zagrijtschuk is employed at Pharmaessentia Corporation, where he continues to work on cutting-edge pharmaceutical innovations. His efforts in drug development are pivotal for enhancing treatment effectiveness and patient outcomes.
Collaborations
Throughout his career, Zagrijtschuk has worked alongside esteemed colleagues such as Christoph Klade and Ko-Chung Lin. These collaborations have enabled him to combine expertise and drive forward innovative solutions in the field of medicine.
Conclusion
Oleh Zagrijtschuk's contributions through his patented inventions and collaborative efforts highlight his vital role in advancing pharmaceutical treatments. As he continues to innovate within Pharmaessentia Corporation, the impact of his work is expected to touch many lives positively in the medical community.